Submission Details
| 510(k) Number | K903882 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 22, 1990 |
| Decision Date | December 04, 1990 |
| Days to Decision | 104 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | — |
K903882 is an FDA 510(k) clearance for the VARICELLA-ZOSTER VIRUS ANTIBODY TEST KIT-LATEX AGG. This device is classified as a Antigen, Cf, (including Cf Control), Varicella-zoster (Class II — Special Controls, product code GQW).
Submitted by Viral Antigens, Inc. (Memphis, US). The FDA issued a Cleared decision on December 4, 1990, 104 days after receiving the submission on August 22, 1990.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3900.
| 510(k) Number | K903882 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 22, 1990 |
| Decision Date | December 04, 1990 |
| Days to Decision | 104 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | — |
| Product Code | GQW — Antigen, Cf, (including Cf Control), Varicella-zoster |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3900 |